Nutrition, Metabolism & Cardiovascular Diseases
Publisher: Elsevier · ISSN 0939-4753 · 80 articles
- The association between ultra-processed food consumption and incidence of cardio-renal-metabolic multimorbidity: Tehran Lipid and Glucose Study
- European Medicines Agency versus Italian Medicines Agency indications for icosapent ethyl: a long and winding road
- Impact of icosapent ethyl on serum lipoand glycoprotein profiles assessed by 1H-NMR. A real-world observational study (IPE-NMR)
- Methodological considerations regarding sample size adequacy for interaction detection
- Comment on “Temporal trends in hyperlipidemia among adults with diabetes mellitus, 1999-2024: Insights from the CDC WONDER database”
- Weight loss as an important mediator of exercise-induced metabolic benefits in metabolic syndrome
- Response to Wang et al.
- Cumulative residual triglyceride exposure associates with arterial stiffness progression independent of LDL-C
- Tolerability of Glucagon-Like Peptide-1 Receptor Agonists (GLP1-RA) in Patients with Type 2 Diabetes Aged Over 75 years: A Retrospective Cohort Study
- Maternal high cholesterol levels and breast milk bioactive composition in the postpartum period: a cross-sectional analysis
- MASLD INFLAMMATORY PHENOTYPING USING LIPIDOMICS AND SUBCLINICAL CORONARY ATHEROSCLEROSIS: A PILOT STUDY
- Lipoprotein(a), Joint Apolipoprotein B and LDL-C/Total Cholesterol Phenotypes, and Incident ASCVD in the UK Biobank
- National and subnational burden of disease attributable to high body mass index in Italy: insights from Global Burden of Disease Study 2023
- Association between plasma long-chain acylcarnitines and long-term mortality and cardiovascular outcomes in patients with coronary artery disease
- Mortality risk associated with health vulnerability profiles is higher among individuals with greater ultra-processed food consumption: prospective findings from the Moli-sani Study
- Paradoxical role of uric acid in stroke
- Eating Behavior Patterns and Cardiometabolic Risk in Adults with Obesity Across Care Settings
- Clinical and Genetic Evidence for the Effects of Glucagon-like peptide-1 Receptor Agonists on Cardiovascular Phenotypes in Metabolic Disorders: An Integrated Meta-Analysis and Drug Target Mendelian Randomization Study
- Trends and Disparities in MASLD and Cardiovascular Disease Related Mortality in the United States
- THE ASSOCIATION BETWEEN BINGE EATING AND THE METABOLIC PROFILE OF ADOLESCENTS WITH OBESITY
- Intensive early and sustained lowering of LDL-C and inflammation after index PCI and Cardiovascular Outcomes
- Editorial Board
- Hyperuricemia, gout and obesity: should weight management be more of a focus in gout management?
- Management of patients with cardiovascular disease and overweight/obesity: expert opinion on semaglutide use
- Dysregulated growth hormone–insulin-like growth factor-1 axis in adults with metabolic dysfunction-associated steatotic liver disease: a meta-analysis
- Coronary artery disease -related outcomes associated with semaglutide and tirzepatide in type 2 diabetes mellitus and obesity: a systematic review and meta-analysis
- The accelerating crisis of metabolic multimorbidity in young U.S. adults: a 26-year analysis of national trends, disparities, and projections to 2031
- Performance of anthropometric, cardiometabolic, and lipid-related indices for metabolic syndrome and low muscle mass in older Mexican adults
- Combined triglyceride–glucose index and body mass index for early cardiovascular risk stratification in adults under 45: Findings from the Kailuan cohort
- The burden of cardiovascular-kidney-metabolic syndrome in high versus upper-middle-income countries: integrated analysis of trends, inequality, and risk factors